Stroke: epidemiology, classification, risk factors, complications, diagnosis, prevention, and medical and dental management

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 102, Issue 2, 2006, Pages 180-191

  Fatahzadeh, Mahnaz ^a   Glick, Michael ^b  

^a Dept Pediat Newark Beth Israel M   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DENTAL CARE; DYSPHAGIA; HUMAN; MOUTH DISEASE; REVIEW; RISK FACTOR; UNITED STATES;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DEGLUTITION DISORDERS; DENTAL CARE FOR CHRONICALLY ILL; FIBRINOLYTIC AGENTS; HUMANS; MOUTH DISEASES; RISK FACTORS; UNITED STATES;

EID: 33746225358     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.07.031     Document Type: Review

References (146)

1. Warlow C., Sudlow C., Dennis M., Wardlow J., and Sandercock P. Stroke. Lancet 362 (2003) 1211-1224
2. Naidech A.M., and Weisberg L.A. Treatment of chronic hypertension for the prevention of stroke. South Med J 96 4 (2003) 359-362
3. Ingall T.J. Preventing ischemic stroke. current approaches to primary and secondary prevention. Postgrad Med 107 6 (2000) 34-50
4. Caplan L.R. Now is an exciting time to care for stroke patients. South Med J 96 4 (2003) 329-330
5. American Heart Association. Heart disease and stroke statistics, 2005 update (2005), American Heart Association, Dallas
6. Broderick J., Brott T., Kothari R., et al. The Greater Cincinnati/Northern Kentucky Stroke Study. preliminary first-ever and total incidence rates of stroke among blacks. Stroke 29 (1998) 415-421
7. Kirshner H.S. Medical prevention of stroke. South Med J 96 4 (2003) 354-358
8. Leary M.C., and Saver J.L. Incidence of silent stroke in the United States (2001) Poster presented at the 26th American Heart Association Stroke Meeting, February, Fort Lauderdale, Fla.
9. Zweifler R.M. Management of Acute Stroke. South Med J 96 4 (2003) 380-385
10. American Heart Association. Targeting the facts (2002), American Heart Association, Dallas
11. Smith W.S., Hauser S.L., and Easton J.D. Cerebrovascular diseases. In: Braunwald E., Hauser S., Fauci A.S., Longo D.L., Kasper D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 15th ed. (2001), McGraw-Hill, New York
12. Feigin V.L., Lawes C.M.M., Bennett D.A., and Anderson C.A. Stroke epidemiology. a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 (2003) 43-53
13. Toole J.F., Sane D.C., and Betterman K. Stroke prevention. optimizing the response to a common threat. JAMA 292 15 (2004) 1885-1887
14. Felberg R.A., and Naidech A.M. The 5 Ps of acute ischemic stroke treatment. parenchyma, pipes, perfusion, penumbra and prevention of complications. South Med J 96 4 (2003) 336-342
15. Felberg R.A., Burgin W.S., and Grotta J.C. Neuroprotection and the ischemic cascade. CNS Spectrs 5 (2000) 52-58
16. Toole J. Vascular diseases. In: Rowland L. (Ed). Merritt's textbook of neurology (1989), Lea & Febiger, Philadelphia
17. Kelley R.E., and Minagar A. Cardioembolic stroke. an update. South Med J 96 4 (2003) 343-349
18. Markesbery W. The central nervous system. In: Golden A., Powell D.E., and Jennings C.D. (Eds). Pathology. Understanding human disease (1985), William & Wilkins, Baltimore
19. Frey J.L., Jahnke H.K., and Bulfinch E.W. Differences in stroke between white, Hispanic, and Native American patients. the Barrow Neurological Institute Stroke Database. Stroke 29 (1998) 29-33
20. Sacco R.L., Ellenberg J.H., Mohr J.P., et al. Infarcts of undetermined cause. The NINCDS Stroke Data Bank. Ann Neurol 25 (1989) 382-390
21. Xavier A., Qureshi A., Kirmani J., Yahia A.M., and Bakshi R. Neuroimaging of stroke. a review. South Med J 96 4 (2003) 367-378
22. Bakshi R., and Ketonen L. Brain MRI in clinical neurology. In: Joynt R.J., and Griggs R.C. (Eds). Baker's clinical neurology on CD-ROM. 2001 edition (2001), Lippincott Williams & Wilkins, Philadelphia
23. Bakshi R. Diffusion-weighted MRI as an evolving standard of care in acute stroke. Neurology 55 (2000) 1595
24. Caplan L.R. Treatment of acute stroke. still struggling. JAMA 292 15 (2004) 1883-1885
25. Fiebach J.B., Schellinger P.D., Geletneky K., et al. MRI in acute subarachnoid hemorrhage. findings with a standardized stroke protocol. Neuroradiology 46 (2004) 44-48
26. Kidwell C.S., Chaleta J.A., Saver J.L., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292 (2004) 1823-1830
27. Fiebach J.B., Schellinger P.D., Gass A., et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage. a multicenter study on the validity of stroke imaging. Stroke 35 (2004) 502-506
28. Schellinger P.D., Janson O., Fiebach J.B., Hacke W., and Sartor K. A standardized MRI stroke protocol. comparison with CT in hyperacute intracerebral hemorrhage. Stroke 30 (1999) 765-768
29. Lhermitte F., Gantier J.C., and Derouesne C. Nature of occlusions of the middle cerebral artery. Neurology 20 (1970) 82-88
30. Wintermark M., Reichhart M., Tiran J.-P., et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission in acute stroke patients. Ann Neurol 51 (2002) 417-432
31. Bitar Sr., Kichura G.M., and Labovitz A.J. Cardiac sources of emboli. The role of trans-esophageal echcardiography. Resid Staff Physician 44 (1998) 53-64
32. Straus S.E., Majumdar S.R., and McAlister F.A. New evidence for stroke prevention. scientific review. JAMA 288 (2002) 1388-1395
33. Petty G.W., Brown R.D., Whisnant J.P., Sicks J.A., O'Fallon W.M., and Wiebers D.O. Ischemic stroke subtypes. A population-based study of functional outcome, survival, and recurrence. Stroke 31 (2000) 1062-1068
34. Woo D., Gebel J., Miller R., et al. Incidence rates of first-ever ischemic stroke subtypes among blacks. a population-based study. Stroke 30 (1999) 2517-2522
35. Gorelick P.B., Sacco R.L., Smith D.B., et al. Prevention of a first stroke. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281 (1999) 1112-1120
36. Hart R.G., Sherman D.G., Easton J.D., and Cairns J.A. Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 51 (1998) 674-681
37. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
38. Hart R.G., Boop B.S., and Anderson D.C. Oral anticoagulants and intracranial hemorrhage. facts and hypotheses. Stroke 26 (1995) 1471-1477
39. Wolf P.A., Clagett G.P., Easton J.D., et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. AHA Scientific Statement. Stroke 30 (1999) 991-994
40. Hachinski V.C., Lassen N.A., and Marshall J. Multi-infarct dementia. a cause of mental deterioration in the elderly. Lancet 2 (1974) 207-210
41. Hier D.B., Foulkes M.A., Swiontoniowski M., et al. Stroke recurrence within 2 years after ischemic infarction. Stroke 22 (1991) 155-161
42. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 358 (2001) 1033-1041
43. Group P.C. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 358 (2001) 1033-1041
44. European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342 (1993) 1255-1262
45. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low intensity, fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 348 (1996) 633-638
46. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342 (1993) 1255-1262
47. Hart R.G., Benavente O., McBride R., and Pearce L.A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation. a meta-analysis. Ann Intern Med 131 (1999) 492-501
48. Broderick J.P., and Hacke W. Treatment of acute ischemic stroke part II. neuroprotection and medical management. Circulation 106 (2002) 1736-1740
49. Ezekowitz M.D., and Levine J.A. Preventing stroke in patients with atrial fibrillation. JAMA 281 (1999) 1830-1835
50. Gurbel P.A., Bliden K.P., Hiatt B.L., and O'Connor C.M. Clopidogrel for coronary stenting. response variability, drug resistance, and the effect pretreatment platelet reactivity. Circulation 107 (2003) 2908-2913
51. Matetzky S., Shenkman B., Guetta V., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 (2004) 3171-3175
52. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 18 (1995) 1421-1428
53. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effects of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med 325 (1991) 445-453
54. Cina C.A., Clase C.M., and Haynes R.B. Carotid endarterectomy for symptomatic carotid stenosis (Cochrane Review on CD-ROM). The Cochrane Library Issue 1 (2001), The Cochrane Library, Oxford
55. European Carotid Surgery Trialists' Collaboration. Randomized trial of endarterectomy for recently diagnosed carotid stenosis. final results of the MRC European Carotid Trial (ECST). Lancet 351 (1998) 1379-1387
56. Ronning O.M., and Guldvog B. Stroke units versus general medical wards, I: twelve-and eighteen-month survival: a randomized, controlled trial. Stroke 29 (1998) 58-62
57. Indredavik B., Bakke F., Slordahl S.A., Rokseth R., and Haheim L.L. Stroke unit treatment improves long-term quality of life. a randomized, controlled trial. Stroke 29 (1998) 895-899
58. Langhorne P., and Dennis M.S. Stroke units. the next 10 years. Lancet 363 (2004) 834-835
59. Broderick J.P., and Hacke W. Treatment of acute ischemic stroke part I. recanalization strategies. Circulation 106 (2002) 1563-1569
60. Larrue V., von Kummer R.R., Muller A., and Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. a secondary analysis of the European-Australian Acute Stroke Study (ECASS II). Stroke 32 (2001) 438-441
61. Quality Standard Subcommittee. American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemia stroke: summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 47 (1996) 835-839
62. NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 28 (1997) 2119-2125
63. Kwiatkowski T., Libman R., Frankel M., et al., NINDS rt-PA Stroke Study Group. The NINDS rt-PA Stroke Study. sustained benefit at one year. Stroke 29 (1998) 288
64. Marler J.R., Tilley B.C., Lu M., et al. Early stroke treatment associated with better outcome; the NINDS rt-PA stroke study. Neurology 55 (2000) 1649-1655
65. Fagan S., Morgenstern L., Petitta A., et al., NINDS rt-PA Stroke Study Group. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology 50 (1998) 883-890
66. Broderick J., Lu M., Jackson C., et al. Apolioprotein E phenotype and the efficacy of ifntravenous t-PA in acute ischemic stroke. Ann Neurol 49 (2001) 736-744
67. del Zoppo G.J., Higashida R.T., Furlan A.J., Pessin M.S., Rowley H.A., and Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke-PROACT Investigators: prolyse in acute cerebral thromboembolism. Stroke 29 (1998) 4-11
68. Furlan A., Higashida R., Wechsler L., et al. Intraarterial pro-urokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282 (1999) 2003-2011
69. Suarez J.I., Sunshine J.L., Tarr R., et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 30 (1999) 2094-2100
70. Bendszus M., Urbach H., Ries F., and Solymosi L. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 40 (1998) 54-58
71. Fisher M., and Schaebitz W. An overview of acute stroke therapy. past, present and future. Arch Int Med 160 (2000) 3196-3206
72. Sherman D.G., and STAT Writers Group. Defibrinogenation with viprinex (ancord) for the treatment of acute ischemic stroke. [abstract]. Stroke 30 (1999) 234
73. Marler J.R., and Lyden P.D. The NINDS t-PA for acute stroke protocol. In: Lyden P.D. (Ed). Thrombolytic therapy for Stroke (2001), Humana, Totowa (NJ) 297-308
74. National Institute of Neurological Disorders, Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
75. Chiu D., Krieger D., Villar Cordova C., et al. Intravenous tissue plasminogen activator for acute ischemic stroke. feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29 (1998) 18-22
76. Engelstein E., Margulies J., and Jeret J.S. Lack of t-PA use for acute ischemic stroke in a community hospital. high incidence of exclusion criteria. Am J Emerg Med 18 (2000) 257-260
77. Chen Z.M., Sandercock P., Pan H.C., et al., On behalf of the CAST and IST Collaborative Groups. Indications for early aspirin use in acute ischemic stroke. a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 31 (2000) 1240-1249
78. Coull B.M., Williams L.S., Goldstein L.B., et al. Anticoagulants and antiplatelet agents in acute ischemic stroke. Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association. Neurology 59 (2002) 13-22
79. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST. randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 349 (1997) 1641-1649
80. International Stroke Trial Collaborative Group. The International Stroke Trial (IST). A randomized trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischemic stroke. Lancet 349 (1997) 1569-1581
81. Atlantis, ECASS, NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment. pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
82. Counsell C., and Sandercock P. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke. Cochrane Database Syst Rev 2 (2000) CD000119
83. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke. a randomized controlled trial. JAMA 279 (1998) 1265-1272
84. Berge E., Abdelnoor M., Nakstad P.H., Sandset P.M., and HAEST Study Group. Low-molecular-weight heparin versus aspirin in patients with acute ischemic stroke and atrial fibrillation: a double-blind randomized study. Heparin in Acute Embolic Stroke Trial. Lancet 355 (2000) 1205-1210
85. Clark W.M., Lutsep H.L., Barnwell S.L., Nesbit G.M., Guterman L.R., Teal P., et al. Multicenter feasibility study of an ultrasound drug infusion microcatheter for treatment of acute ischemic stroke. [Abstract]. Stroke 33 (2002) 359
86. Ueda T., Sakaki S., Nochide I., Kumon Y., Kohno K., and Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 29 (1998) 2568-2574
87. Ernst R., Pancioli A., Tomsick T., et al. Combined intravenous and intra-arterial r-TPA in acute ischemic stroke. Stroke 31 (2000) 2552-2557
88. Qureshi A.I., Ali Z., Suri M.F., et al. Intra-arterial third-generation r-TPA (reteplase) for acute ischemic stroke. Neurosurgery 49 (2001) 41-50
89. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke. a randomized, double blind, placebo-controlled, dose-escalation study. Stroke 31 (2000) 601-609
90. Wojner A.W., El-Mitwalli A., and Alexandrov A.V. Effect of head positioning on intracranial blood flow velocities in acute ischemic stroke. a pilot study. Crit Care Nurs Q 24 (2002) 57-66
91. Schwarz S., Georgiadis D., Aschoff A., et al. Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 33 (2002) 497-501
92. Lewandowski C., and Barsan W. Treatment of acute ischemic stroke. Ann Emerg Med 37 (2001) 202-216
93. Hajat C., Hajat S., and Sharma P. Effects of post-stroke pyrexia on stroke outcome. a meta-analysis of studies in patients. Stroke 31 (2000) 410-414
94. Ginsberg M.D., and Busto R. Combating hyperthermia in acute stroke. a significant clinical concern. Stroke 29 (1998) 529-534
95. Lees K. Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke 33 (2002) 308-309
96. Hacke W., Schwab S., Horn M., Spranger M., De Georgia M., and von Kummer R. "Malignant" middle cerebral artery territory infarction. clinical course and prognostic signs. Archiv Neurol 53 (1996) 309-315
97. Kelly J., Rudd A., Lewis R., and Hunt B.J. Venous thromboembolism after stroke. Stroke 32 (2001) 262-267
98. Dromerick A.W., and Abdul Khader S.A. Medical complications during stroke rehabilitation. Advances in neurology 92 (2003) 409-413
99. Iranzo A., Santamaria J., Berenguer J., Sanchez M., and Chamorro A. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology 58 (2002) 911-916
100. Sandberg O., Franklin K.A., Bucht G., and Gustafson Y. Sleep apnea, delirium, depressed mood, cognition, and ADL ability after stroke. J Am Geriatr Soc 49 (2001) 391-397
101. Ostuni E. Stroke and the dental patient. J Am Dent Assoc 125 (1994) 721-727
102. In: Helm-Estrabrook N., and Albert M. (Eds). A manual for aphasic therapy (1991), Pro-Ed, Austin (TX) 159
103. Weisberg L.A. "Stroke and Struck". protecting the brain from cerebrovascular disease. South Med J 96 (2003) 331
104. Gupta A., Pansari K., and Shetty H. Post-stroke depression. Int J Clin Pract 56 (2002) 531-537
105. Narushima K., and Robinson R.G. Stroke-related depression. Curr Atheroscler Rep 4 (2002) 296-303
106. Swindle C.S., and Hammons J. Post-stroke depressions. neurologic, physiologic, diagnostic, and treatment implications. J Speech Hear Res 34 (1991) 325-333
107. Kase C.S., Wolf P.A., Kelly-Hayes M., Kannel W.B., Beiser A., and D'Agostino R.B. Intellectual decline after stroke. the Framingham Study. Stroke 29 (1998) 805-812
108. Skoog I., Nilsson L., Palmertz B., Andreasson L.A., and Svanborg A. A population based study of dementia in 85-year-olds. N Engl J Med 328 (1993) 153-158
109. Giaquinto S., Buzzelli S., Di Francesco L., and Nolfe G. Evaluation of sexual changes after stroke. J Clin Psych 64 3 (2003) 302-307
110. Kimura M., Murata Y., Shimoda K., and Robinson R.G. Sexual dysfunction following stroke. Compr Psych 42 3 (2001) 217-222
111. Yokota C., Minematsu K., Hasegawa Y., and Yamaguchi T. Long-term prognosis, stroke subtypes, after a first-ever stroke. a hospital-based study over a 20-year period. Cerebrovasc Dis 18 2 (2004) 111-116
112. Dombovy M.L., Basford J.R., Whisnant J.P., and Bergstralh E.J. Disability and use of rehabilitation services following stroke in Rochester, Minnesota. 1975-79. Stroke 18 (1987) 830-836
113. Dobkin B.H. Rehabilitation after stroke. N Engl J Med 352 (2005) 1677-1684
114. Little J.W., Falace D.A., Miller G.S., and Rhodus N.L. Neurological disorders. In: Little J.W., Falace D.A., Miller G.S., and Rhodus N.L. (Eds). Dental management of the medically compromised patient (2002), Mosby, St Louis 417-438
115. In: Wertz R.T., La Point L.L., and Rosenbeck J.C. (Eds). Apraxia of speech in adults. the disorder and its management (1984), Grun & Stratton, New York
116. Gordon C., Langton H.R., and Wadw D. Dysphagia in acute stroke. Br Med J 295 (1987) 411-414
117. Shapiro S., Irwin M., and Hamby C.L. Dysphagia and the elderly. an emerging challenge for dentistry. J Okla Dent Assoc 81 (1991) 20-25
118. Ciarrocca K.N., Greenberg M.S., and Garfunkel A. Neuromuscular diseases. In: Greenberg M., and Glick M. (Eds). Burket's oral medicine diagnosis and treatment (2003), Decker, Hamilton (BC) 592-605
119. Scannapieco F.A., Bush R.B., and Paju S. Association between periodontal disease and risk for atherosclerosis, cardiovascular disease and stroke. A systematic review. Ann Periodontol 8 1 (2003) 38-53
120. Grau A.J., Buggle F., Ziegler C., Schwarz W., Meuser J., and Tasman A.J. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 28 (1997) 1724-1729
121. Desvarieux M., Demmer R.T., Rundek T., et al. Periodontal microbiota and carotid intima-media thickness. the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111 (2005) 576-582
122. Syrjanen J., Peltola J., Valtonen V., Iivanainen M., Kaste M., and Huttunen J.K. Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med 225 (1989) 179-184
123. Friedlander A.H., and Friedlander I.K. Identification of stroke prone patients by panoramic radiography. Aust Dent J 43 1 (1998) 51-54
124. Carter L., Haller A.D., Nadarajah V., Calamel A.D., and Aguirre A. Use of panoramic radiography among an ambulatory dental population to detect patients at risk of stroke. J Am Dent Assoc 128 (1997) 977-984
125. Friedlander A.H., Garrett N.R., Chin E.E., and Baker J.D. Ultrasonographic confirmation of carotid artery atheromas diagnosed via panoramic radiography. J Am Dent Assoc 136 4 (2005) 635-640
126. Doris I., Dobranowski J., Franchetto A.A., and Jaeschke R. The relevance of carotid artery calcifications in patients on plain radiograph. Stroke 24 9 (1993) 1330-1334
127. Dempsey R., Diana A.L., and Moore R. Thickness of carotid artery atherosclerotic plaque and ischemic risk. Neurosurgery 27 3 (1990) 343-348
128. Wolf P.A., D'Agostino R.B., Belanger A.J., and Kannel W.B. Probability of stroke. a risk profile from the Framingham Study. Stroke 22 (1991) 312-318
129. Burn J., Dennis M., Bamford J., Sandercock P., Wade D., and Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 25 2 (1994) 333-337
130. Leira E.C., Chang K.C., Davis P.H., Clarke W.R., Woolson R.F., Hansen M.D., and Adams Jr. H.P. Can we predict early recurrence in acute stroke?. Cerebrovasc Dis 18 (2004) 139-144
131. Sacco R.L., Foulkes M.A., Mohr J.P., Wolf P.A., Hier D.B., and Price T.R. Determinants of early recurrence of cerebral infarction. The Stroke Data Bank. Stroke 20 (1989) 983-989
132. Ardekian L., Gaspar R., Peled M., Brener B., and Laufer D. Does low-dose aspirin therapy complicate oral surgical procedures?. J Am Dent Assoc 131 (2000) 331-335
133. Johnson-Leong C., and Rada R.E. The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy. J Am Dent Assoc 133 8 (2002) 1083-1087
134. Wahl M.J. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc 131 (2000) 77-81
135. Jeske A.H., and Suchko G.D. ADA Council on Scientific Affairs and Division of Science. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc 134 11 (2003) 1492-1497
136. Blinder D., Manor Y., Martinowitz U., Taicher S., and Hashomer T. Dental extractions in patients maintained on continued oral anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 (1999) 137-140
137. Gage B.F., Fihn S.D., and White R.H. Warfarin therapy for an octogenarian who has atrial fibrillation. Ann Intern Med 134 6 (2001) 465-474
138. Wells P.S., Holbrook A.M., Crowther N.R., and Hirsh J. Interactions of warfarin with drugs and food. Ann Inter Med 121 (1994) 676-683
139. Wynn R.L. Dental nonsteroidal antiinflammatory drugs and prostaglandin-based drug interactions, part one. Gen Dent 40 1 (1992) 18-20
140. Carr M.M., and Mason R.B. Dental management of anticoagulated patients. J Can Dent Assoc 58 (1992) 833-844
141. Rice P.J., Perry R.J., Afzal Z., and Stockley I.H. Antibacterial prescribing and warfarin. a review. Br Dent J 194 8 (2003) 411-415
142. Searcy R.L., Foreman J.A., Myers H.D., and Bergquist L.M. Anticoagulant properties of tetracyclines. Antimicrobial Agent & Chemotherapy 161 (1963) 471-476
143. O'Donnell D. Antibiotic-induced potentiation of oral anticoagulant agents. Med J Aust 150 (1989) 163-164
144. Dean R.P., and Talbert R.L. Bleeding associated with concurrent warfarin and metronidazole therapy. Drug Intell Clin Pharm 14 (1980) 864
145. Rose L.F., Mealey B., Minsk L., and Cohen D.W. Oral care for patients with cardiovascular disease and stroke. J Am Dent Assoc 133 Suppl (2002) 37S-44S
146. Leung K.C., Pow E.H., McMillan A.S., Wong M.C., Li L.S., and Ho S.L. Oral perception and oral motor ability in edentulous patients with stroke and Parkinson's disease. J Oral Rehabil 29 (2002) 497-503